[3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease. 1985

C Pimoule, and H Schoemaker, and G P Reynolds, and S Z Langer

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001552 Benzazepines Compounds with BENZENE fused to AZEPINES.
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D013134 Spiperone A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA. Spiroperidol,Spiroperone

Related Publications

C Pimoule, and H Schoemaker, and G P Reynolds, and S Z Langer
April 1986, Life sciences,
C Pimoule, and H Schoemaker, and G P Reynolds, and S Z Langer
January 1989, Journal of receptor research,
C Pimoule, and H Schoemaker, and G P Reynolds, and S Z Langer
April 1990, The Journal of pharmacology and experimental therapeutics,
C Pimoule, and H Schoemaker, and G P Reynolds, and S Z Langer
June 1986, Brain research,
C Pimoule, and H Schoemaker, and G P Reynolds, and S Z Langer
June 1994, European journal of pharmacology,
C Pimoule, and H Schoemaker, and G P Reynolds, and S Z Langer
January 1987, Journal of neural transmission,
C Pimoule, and H Schoemaker, and G P Reynolds, and S Z Langer
January 1986, Advances in experimental medicine and biology,
C Pimoule, and H Schoemaker, and G P Reynolds, and S Z Langer
January 1986, Psychopharmacology bulletin,
C Pimoule, and H Schoemaker, and G P Reynolds, and S Z Langer
March 1990, The Journal of pharmacology and experimental therapeutics,
C Pimoule, and H Schoemaker, and G P Reynolds, and S Z Langer
September 1986, Lancet (London, England),
Copied contents to your clipboard!